Serologic concentrations of HER-2/neu in breast cancer patients with visceral metastases receiving trastuzumab therapy predict the clinical course

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical chemistry (Baltimore, Md.) Md.), 2002-08, Vol.48 (8), p.1360-1362
Hauptverfasser:	SCHÖNDORF, Thomas, HOOPMANN, Markus, WARM, Mathias, NEUMANN, Rainer, THOMAS, Anke, GÖHRING, Uwe-Jochen, EISBERG, Carsten, MALLMANN, Peter
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Antineoplastic Agents - therapeutic use Biological and medical sciences Biomarkers, Tumor - blood Breast Neoplasms - diagnosis Breast Neoplasms - drug therapy Breast Neoplasms - pathology Female Gynecology. Andrology. Obstetrics Humans Mammary gland diseases Medical sciences Middle Aged Mucin-1 - blood Neoplasm Metastasis Prognosis Receptor, ErbB-2 - blood Trastuzumab Tumors Viscera
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!